Retatrutide is a new medication in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By activating these receptors, https://harmonytpai905830.newbigblog.com/42513886/tirzepatide-a-promising-new-treatment-for-obesity